AEF0117

DRUG4 trials

Sponsors

Aelis Farma

Conditions

Healthy VolunteersMarijuana Abuse

Phase 1

Single Ascending Dose to Study the Safety, Tolerability, PK and PD Effects of AEF0117

CompletedNCT03325595

Aelis FarmaHealthy Volunteers

Start: 2017-04-06End: 2018-02-26Updated: 2018-03-13

Study of [4-14C] AEF0117 Following a Single Oral Dose in Healthy Male Subjects

CompletedNCT05554926

Aelis FarmaMarijuana Abuse

Start: 2022-12-16End: 2023-02-24Updated: 2023-04-07

Phase 2

Effect of AEF0117 on Subjective Effects of Cannabis in CUD Subjects

CompletedNCT03717272

Aelis FarmaMarijuana Abuse

Start: 2018-10-23End: 2021-01-01Updated: 2021-06-02

Effect of AEF0117 on Treatment-seeking Patients With Cannabis Use Disorder (CUD)

CompletedNCT05322941

Aelis FarmaMarijuana Abuse

Start: 2022-05-06End: 2024-07-22Updated: 2024-07-30

Related Papers

Signaling-specific inhibition of the CB<sub>1</sub> receptor for cannabis use disorder: phase 1 and phase 2a randomized trials.

2023-06-0833 citations